A new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer’s disease (AD) is beginning enrollment at Emory University and University of California, Irvine. It is the first clinical trial in the U.S. to use this stem cell-based treatment.
from Dementia Big http://ift.tt/2aKYGNt via alcoholic dementia
http://ift.tt/2aoEi3R
No comments:
Post a Comment